Home300601 • SHE
add
Shenzhen Kangtai Biological Prods Co Ltd
Previous close
¥15.59
Day range
¥15.31 - ¥15.67
Year range
¥13.10 - ¥21.12
Market cap
17.49B CNY
Avg Volume
12.41M
P/E ratio
-
Dividend yield
0.58%
Primary exchange
SHE
Market news
Financials
Income Statement
Revenue
Net income
| (CNY) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 671.38M | -17.74% |
Operating expense | 425.29M | -2.76% |
Net income | 11.62M | -93.74% |
Net profit margin | 1.73 | -92.40% |
Earnings per share | — | — |
EBITDA | 212.79M | -40.14% |
Effective tax rate | -3,472.08% | — |
Balance Sheet
Total assets
Total liabilities
| (CNY) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.65B | 431.20% |
Total assets | 14.13B | -2.63% |
Total liabilities | 4.52B | -5.87% |
Total equity | 9.61B | — |
Shares outstanding | 1.12B | — |
Price to book | 1.81 | — |
Return on assets | 2.39% | — |
Return on capital | 2.94% | — |
Cash Flow
Net change in cash
| (CNY) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 11.62M | -93.74% |
Cash from operations | 286.87M | 60.54% |
Cash from investing | 676.05M | 357.44% |
Cash from financing | -44.23M | -4.17% |
Net change in cash | 918.51M | 825.91% |
Free cash flow | -1.08B | 43.85% |
About
Shenzhen Kangtai Biological Products, also known as BioKangtai, is a Chinese biopharmaceutical company that develops, manufactures and markets vaccines and other vaccine products.
Kangtai develops the Minhai COVID-19 vaccine and has the exclusive right to manufacture the Oxford–AstraZeneca COVID-19 vaccine in mainland China. Wikipedia
Founded
Sep 8, 1992
Website
Employees
1,913
